[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342169-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342169-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","anti-cancer-effect-of-sulforaphane-in-human-pancreatic-cancer-cells-mia-paca-2","Anti-Cancer Effect of Sulforaphane in Human Pancreatic Cancer Cells Mia PaCa-2","","Sulforaphane (SFN), a natural compound found in cruciferous vegetables, is investigated for anti-cancer activity against the human pancreatic cancer cell line Mia PaCa-2. The study focuses on the glycogen synthase kinase-3 beta (GSK-3β)–related pathway and how it regulates apoptosis and tumor survival signaling. SFN suppresses the GSK3β/NF-κB/cMyc axis, decreases NF-κB and cMyc, reduces BCL-2, increases BAX, and promotes cleavage of caspase-3 and PARP, supporting therapeutic potential in pancreatic cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/anti-cancer-effect-of-sulforaphane-in-human-pancreatic-cancer-cells-mia-paca-2/342169/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/anti-cancer-effect-of-sulforaphane-in-human-pancreatic-cancer-cells-mia-paca-2/342169.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is targeting GSK-3β relevant to pancreatic cancer?","Question",{"text":63,"@type":64},"GSK-3β regulates multiple aspects of pancreatic cancer progression, including proliferation, apoptosis, EMT, and treatment resistance, and targeting it can potentially improve chemotherapy effectiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does sulforaphane affect the GSK-3β/NF-κB/cMyc pathway in Mia PaCa-2 cells?",{"text":68,"@type":64},"SFN increases related β-catenin proteins but ultimately decreases NF-κB and cMyc expression, indicating inhibition of proliferation through suppression of the GSK3β/NF-κB/cMyc pathway.",{"name":70,"@type":61,"acceptedAnswer":71},"What apoptosis-related changes does SFN induce?",{"text":72,"@type":64},"SFN inhibits BCL-2 expression, increases the BAX ratio, and promotes cleavage of caspase-3 and PARP, supporting apoptosis activation in Mia PaCa-2 cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342169,1790825491,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nAnti-Cancer Effect of Sulforaphane in Human Pancreatic Cancer Cells Mia PaCa-2  \nMin Ju Park | Yoon Hee Kim   \nDepartment of Food and Nutrition, College of Engineering, Daegu University, Gyeongsan-Si, Gyeongsangbuk-do, Republic of Korea Correspondence: Yoon Hee Kim ([kimyh0128@daegu.ac.kr](kimyh0128@daegu.ac.kr))  \nReceived: 3 January 2024 | Revised: 28 October 2024 | Accepted: 21 November 2024  \nKeywords: anticancer | apoptosis | GSK-3β | pancreatic cancer | sulforaphane  \nABSTRACT  \nBackground: Pancreatic cancer is difficult to treat early as it has no early symptoms. The presence of sulforaphane (SFN) incruciferous vegetables has been found to possess anti-cancer effects in gastric and colon cancers. Glycogen synthase kinase-3 beta (GSK-3β), a serine/threonine kinase, plays a significant role in pancreatic cancer progression, influencing tumor growth, metastasis, and treatment resistance. Targeting GSK-3β has shown potential to enhance the efficacy of chemotherapy. However, the mechanism underlying the anticancer effects of SFN on pancreatic cancer through GSK-3β is unclear.  \nAims: In this study, we examined the anticancer effects of SFN in human pancreatic cancer cell line Mia PaCa-2 and evaluated its molecular mechanisms with respect to the GSK-3β-related pathway.  \nMethods and Results: SFN increased the protein expression of the phosphorylated form of GSK3β (Ser9) . In the Wingless Int-1 homolog/β-catenin pathway, GSK3β induced apoptosis by phosphorylating β-catenin. However, in mutant Kirsten rat sarcoma viral oncogene homolog-like-dependent cells such as Mia PaCa-2, GSK3β was suppressed and the β-catenin level was increased, thus inducing apoptosis. Indeed, SFN increased the protein expression of β-catenin in the cytoplasm and nucleus. Subsequently, we measured the level ofcMyc, the target gene of β-catenin. SFN decreased cMyc expression despite an increase in the β-catenin. We measured the expression of nuclear factor (NF)-κB, a downstream factor of GSK3β and an upstream factor of cMyc. SFN decreased the expression of NF-κB and cMyc, indicating that SFN inhibits cell proliferation by suppressing the GSK3β/NF-κB/ cMyc pathway. As the suppression of NF-κB results in a decrease in B-cell lymphoma 2 (BCL-2) which is the anti-apoptotic gene, we tested the effect of SFN in the expression of BCL-2. SFN inhibited the expression of BCL-2 and increased the ratio of theapoptotic regulator gene BCL-2 associated X (BAX), where SFN induced the cleaved cysteine aspartase-3 and poly-adenosine diphosphate ribose polymerase.  \nConclusion: These results indicate that SFN may have therapeutic potential in the inhibition of pancreatic cancer.  \n1 | Introduction  \nAccording to the 2020 current status report on the incidence of main cancer types by the National Cancer Information Center, pancreatic cancer ranks eighth in terms of commonality, with a crude incidence rate of 16.4% . The mortality of pancreatic cancer, however, is ranked fifth, and the 5-year relative survival is low at 15.2% compared to that of other cancer types in both  \nmales and females [1] . The high mortality and low survival may be due to the lack of biological markers or radiological tests for early diagnosis, leading to over 80% of pancreatic cancer being diagnosed as a cancer that prevents radical resection. Chemotherapy is thus crucial in the treatment of pancreatic cancer [2] . Gemcitabine has been applied in standard systemic chemotherapy since the 1990s; however, numerous ongoing studies are investigating ways to overcome the clinical limitations of  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2024; 7:e70074 1 of 9  \n[https://doi.org/10.1002/cnr2.70074](https://doi","cbCairO65FZECIRo","https://ap.wps.com/l/cbCairO65FZECIRo","pdf",1974571,"English","# Introduction\n## Background on pancreatic cancer and treatment challenges\n## SFN and reported anticancer actions\n## Rationale for targeting GSK-3β\n# Abstract\n## Background\n## Aims\n## Methods and Results\n## Conclusion","[{\"question\":\"Why is targeting GSK-3β relevant to pancreatic cancer?\",\"answer\":\"GSK-3β regulates multiple aspects of pancreatic cancer progression, including proliferation, apoptosis, EMT, and treatment resistance, and targeting it can potentially improve chemotherapy effectiveness.\"},{\"question\":\"How does sulforaphane affect the GSK-3β/NF-κB/cMyc pathway in Mia PaCa-2 cells?\",\"answer\":\"SFN increases related β-catenin proteins but ultimately decreases NF-κB and cMyc expression, indicating inhibition of proliferation through suppression of the GSK3β/NF-κB/cMyc pathway.\"},{\"question\":\"What apoptosis-related changes does SFN induce?\",\"answer\":\"SFN inhibits BCL-2 expression, increases the BAX ratio, and promotes cleavage of caspase-3 and PARP, supporting apoptosis activation in Mia PaCa-2 cells.\"}]","Anti-Cancer Effect of Sulforaphane in Human Pancreatic Cancer Cells Mia PaCa-2 | PDF",1790045658,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3728cadeb5a1fe0c831d17a3d5d1f2bf.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41a4e84e9b2f5a86d20eab741cf7cde3.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79b1cf017334af06e45012001083c07b.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89fe37954a38296b477aa1ed9b33fd37.webp",980,1287]